Acta Haematologica

Article	Citations
Systematic Review of Microthrombi in COVID-19 Autopsies	39
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic	31
Accelerated Phase of Myeloproliferative Neoplasms	29
Hematological Manifestations among Patients with Rheumatic Diseases	23
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel	18
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations	18
COVID-19 Coagulopathy: From Pathogenesis to Treatment	18
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis	12
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs	12
COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response	11
Current Understandings of Myeloid Differentiation Inducers in Leukemia Therapy	10
Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant	10
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma	10
Adherence to Immunization: Rebuttal of Vaccine Hesitancy	10
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk	10
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment	10
<b><i>BCR/ABL1</i></b>-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy	10
Photon Counting Detector Computed Tomography: A New Frontier of Myeloma Bone Disease Evaluation	9
Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?	8
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Ac	8
Vaccination for SARS-CoV-2 in Hematological Patients	8
Kinase Inhibitors and Interferons as Other Myeloid Differentiation Inducers in Leukemia Therapy	8
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy	8
Consolidation Treatment for Primary Central Nervous System Lymphoma: Which Modality for Whom?	8
Viscoelastic Coagulation Monitor (VCM<sup>Vet</sup>) Reference Intervals and Sex Differences in Mature Adult Mice	8

Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma	8
Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm	8
Deoxycytidine Kinase (DCK) Mutations in Human Acute Myeloid Leukemia Resistant to Cytarabine	7
Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids	7
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review	7
Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation	6
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes	6
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments	6
Chronic Lymphocytic Leukemia: Disease Biology	6
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients	6
Efficacy and Incidence of Treatment-Related Adverse Events of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Network Meta-Analysis of Randomized Contr	5
Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation	5
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response	5
A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination	5
Absolute Immature Platelet Counts Suggest Platelet Production Suppression during Complicated Relapsing Thrombotic Thrombocytopenic Purpura	5
Prognostic Markers in the Era of Targeted Therapies	5
Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia	5
Two Cases of Possible Familial Chronic Myeloid Leukemia in a Family with Extensive History of Cancer	5
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation	5
A Gene Signature Comprising Seven Pyroptosis-Related Genes Predicts Prognosis in Pediatric Patients with Acute Myeloid Leukemia	4
Myeloid Sarcoma: Diagnostic and Treatment Tools from a Monocentric Retrospective Experience	4
Extracellular Vesicles Derived from Human Bone Marrow Stem Cells Inhibit Acute Lymphoblastic Leukemia Cell Growth by Inhibiting MAPK Pathway via the miR-29b-3p/GDF15 Axis	4
Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-	4
Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype	4
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study	4
Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review	4
Efficacy of Individualized Preventive Treatment of Patients with Severe Hemophilia A Guided by Multiple Clinical Parameters and Pharmacokinetics	4
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis	4
Chronic Eosinophilic Leukaemia Associated with <b><i>JAK2</i></b> Exon 13 Insertion/Deletion Mutations	4
How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?	4
Gilteritinib in Isolated Breast Relapse of <b><i>FLT3</i></b> Positive Acute Myeloid Leukemia: A Case Report and Review of Literature	4
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients	4
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series	4
Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor	4
Survival Disparities in Multiple Myeloma by Health Insurance Status among US Non-Elderly Adults: A SEER-Based Comparative Analysis	4
Clinical Significance of Plasma Epstein-Barr Virus DNA in Peripheral T-Cell Lymphomas	4
Increased Plasma GDF15 Is Associated with Altered Levels of Soluble VEGF Receptors 1 and 2 in Symptomatic Multiple Myeloma	4
Frontline Therapy in Chronic Lymphocytic Leukemia	3
Fostamatinib or Thrombopoietin for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost	3
Patient Involvement in the Transfusion Decision-Making Can Change Patient Blood Management Practice for Better or Worse	3
Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany	3
Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?	3
Association between Platelet-Associated Immunoglobulin G Levels and Response to Corticosteroid Therapy in Patients with Newly Diagnosed Immune Thrombocytopenia	3
Safety and Feasibility Analysis of a Prospective Trial on Stereotactic Body Radiotherapy for Solitary Bone Plasmacytoma	3
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies	3
Optimal Post-Remission Consolidation Therapy in Patients with AML	3
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient	3
Tanshinone IIA Inhibits Tissue Factor Expression Induced by Thrombin in Human Umbilical Vein Endothelial Cells via PAR-1 and p38 MAPK Signaling Pathway	3
Use of Core-Needle Biopsy for the Diagnosis of Malignant Lymphomas in Clinical Practice	3
The Mechanistic Effects and Clinical Applications of Various Derived Mesenchymal Stem Cells in Immune Thrombocytopenia	3

Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia	3
STAT3 Promotes Cell Proliferation by Potentiating the CCL4 Transcriptional Activity in Diffuse Large B-Cell Lymphoma	3
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling	3
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa	3
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices	3
Significance of the p.Phe218Ser and p.Gly304Glu F5 Variants in Hereditary Factor V Deficiency	3
Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19	3
Fluoroquinolone Prophylaxis during Conventional Chemotherapy or Hematopoietic Stem Cell Transplantation for Acute Leukemia – Pros and Cons	2
Platelet miR-107 Participates in Clopidogrel Resistance after PCI Treatment by Regulating P2Y12	2
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia in Association with Antiphospholipid Syndrome	2
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient	2
Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine	2
Efficacy of Preexposure Prophylaxis with Monoclonal Antibody Tixagevimab-Cilgavimab against Emerging SARS-CoV-2 Resistant Variants in Patients with Chronic Lymphocytic Leukemia	2
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment	2
Physician’s Subjective Increase in Awareness towards Perioperative Anaemia, Patient’s Blood Resource, and Transfusion after the Implementation of Patient Blood Management: A Nationwide Multicentre Sur	2
Total Platelet Transcriptomics and Its Network Analysis by RNA-Seq and miRNA-Seq and PCA Application in Essential Thrombocythaemia	2
Analysis of Hematological Indices and Splenectomy Rates in 2,130 Patients with Hemoglobin H Diseases or β-Thalassemia	2
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient	2
Acute Myeloid Leukemia Treatment in the Elderly: A Comprehensive Review of the Present and Future	2
Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms	2
Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar	2
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia	2
Preliminary Study on Apoptotic Proteins in Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura	2
Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β<sup>0</sup>-Thalassemia/Hemoglobin E Patients	2
Neuropsychiatric Derangement by Polycythemia Vera: A Case Report of an Unexpected Disease Presentation and Review of the Literature	2
Tumor Lysis Syndrome Is Associated with Worse Outcomes in Adult Patients with Acute Lymphoblastic Leukemia	2
Monitoring Minimal Residual Disease in <b><i>RUNX1</i></b>-Mutated Acute Myeloid Leukemia	2
“Don’t Add Fuel to the Fire”– Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β<sup>0</sup>-Thalassemia: Case Report and Review of the Literature	2
Timing of Initiation of Calcineurin Inhibitors in Pediatric Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: Effects on Survival, Relapse, and Cytokine Release Syndrome	2
Cytokine and Gene Expression Profiling in Patients with <b><i>HFE</i></b>-Associated Hereditary Hemochromatosis according to Genetic Profile	2
The Role of Iron Staining in Myelodysplastic Syndromes: A Treasure Trove of Information	2
Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report	2
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over	2
Macrocytosis in Mitochondrial DNA Deletion Syndromes	2
High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia	2
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective	2
Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report	2
A Patient with Kabuki Syndrome Mutation Presenting with Very Severe Aplastic Anemia	2
Make Family Caregivers Visible, Valued, and Supported: An Interview with Patients’ Caregivers’ Advocate	2
Role of Inherited Thrombophilia Risk Factors in Patients with CKD-5 Receiving Haemodialysis	2
The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents	2
Myeloid Neoplasm with <b><i>PCM1-PDGFRB</i></b> Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review	2
Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 2024	2
Antithrombin Activity Is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness	2
TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Current Guidelines, Therapies, and Future Considerations	2
Prognostic Value of Microvessel Density in Non-Hodgkin Lymphoma: A Meta-Analysis	2
A Novel ANK1 Mutation in a Neonatal Hereditary Spherocytosis Case: Diagnostic Challenges and Familial Genetic Analysis	2
Leg Ulcers: A Report in Patients with Hemoglobin E Beta Thalassemia and Review of the Literature in Severe Beta Thalassemia	2
Anemia in Celiac Disease: Multiple Aspects of the Same Coin	2
“The Long Journey of Unexplained Erythrocytosis”: Erythrocytosis due to High-Oxygen Affinity Hemoglobinopathy – Hemoglobin Variant Little Rock (HBB: c.432C&gt;A) – A Report of a Swiss Family and R	2
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022	2
The Effect of Iron Overload on the Mobilization of Peripheral Blood Hematopoietic Stem Cells in Pediatric Patients with Thalassemia Major	1
Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond	1
Prognostic Factors of Adult Hemophagocytic Lymphohistiocytosis and Clinical Utility of HLH-2004 Diagnostic Criteria and HScore: A Real-World Multicenter Study from Thailand	1
Unusual Clinical Presentations of Hairy Cell Leukemia	1
Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis	1
Relevant Clinical Factors in Patients with Myelofibrosis on Ruxolitinib for 5 or More Years	1
An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia after Experiencing Pleural Effusion during Dasatinib Therapy	1
Glomerulonephritis Secondary to Acute Promyelocytic Leukemia that Resolved after Induction Therapy	1
Utility of Galactomannan Screening for Early Detection of Invasive Aspergillosis in High-Risk Hemato-Oncology Patients	1
Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients	1
High Rates of Anti-αIIbβ3 Antibodies Produced by a Glanzmann Thrombasthenia Patient after First and Unique Red Blood Cells Administration	1
Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study	1
Recapitulated Late-Onset Inflammatory Toxicities and Progressive Dysautonomia with Persistence of Central Memory CD4+ Chimeric Antigen Receptor T Cells in a Case of Transformed Follicular Lymphoma: Ca	1
A Systematic Review Assessing the Underrepresentation of Cancer Patients in COVID-19 Trials	1
Congenital Fibrinogen Deficiency in India and Role of Human Fibrinogen Concentrate	1
Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and IDH2 Mutations	1
A Novel Homozygous Frameshift Mutation in ITGB3 Causes Glanzmann’s Thrombasthenia	1
Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients	1
A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices	1
Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study	1
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region	1
Gene Variants in Two Families with Inherited Coagulation Factor XI Deficiency and Identification of Mutations	1
Shikonin Exerts an Antileukemia Effect against FLT3-ITD Mutated Acute Myeloid Leukemia Cells via Targeting FLT3 and Its Downstream Pathways	1
Lenalidomide Treatment of Isolated Central Nervous System Relapse in Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy	1
Imaging of Hematological Patients in the Era of COVID-19	1
Improvements in Communication and Coordination of Care in a Hemophilia Treatment Center	1
Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements	1
Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells	1
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Blood Safety	1

A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: A Case Report and Literature Review	1
Disparity Analysis of Clinical Features and Prognostic Evaluation of Hemophagocytic Lymphohistiocytosis in Pediatric and Adult Patients: A Retrospective Multicenter Study of 525 Cases in HHLWG	1
Splenic Micronodular T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis	1
Antigen Expression Varies Significantly between Molecular Subgroups of Acute Myeloid Leukemia Patients: Clinical Applicability Is Hampered by Establishment of Relevant Cutoffs	1
Novel JAK2 Exon 14 Mutations L611S or N622Y in cis with JAK2V617F Are Associated with Distinct Clinical Phenotype of Polycythemia Vera and Concurrent Eosinophilia	1
Neutropenia in the First Cycle of Consolidation Chemotherapy with High-Dose Cytarabine Is Not Associated with the Incidence of Relapse in Adult Acute Myeloid Leukemia Patients in First Complete Remiss	1
Acquired Von Willebrand Syndrome following a SARS-CoV2 Infection	1
A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic	1
HLA-DRB5 Overexpression Promotes Platelet Reduction in Immune Thrombocytopenia Mice Model by Facilitating MHC-II-Mediated Antigen Presentation	1
Post-Chemotherapy Histiocyte-Rich Pseudotumors: Radiologic and Endoscopic Mimics of Residual Lymphoma	1
Limited Efficacy of Venetoclax Combination Regimens in Acute Myeloid Leukemia with Extramedullary Relapse	1
Pathophysiology of Acute Myeloid Leukemia	1
Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease	1
Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia	1
Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-Leukemia Effects via HLA-B Leader in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation	1
Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome	1
The Challenging Management of Acute Thrombotic Microangiopathy in Pregnancy	1
A Longitudinal Assessment of the Natural Change in Haemoglobin, Haematocrit, and Mean Corpuscular Volume with Age	1
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement	1
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients	1
Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia	1
Successful Cord Blood Transplantation for Idiopathic CD4<sup>+</sup> Lymphocytopenia	1
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden	1
Machine Learning for the Prediction of Survival Post-Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience	1
T-Lymphoblastic Leukemia/Lymphoma and Thymoma: A Case Report and Review of the Literature of a Rare Association	1
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort	1
Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease Inpatients: Systematic Review and Meta-Analysis	1
Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide	1
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation	1
A Hematoma in the Anterior Abdominal Muscle in a Woman Receiving Venlafaxine: A Literature Review of the Reports on Similar Cases	1
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report	1
Preliminary Investigation about the Expression of G Protein-Coupled Receptors in Platelets from Patients with Chronic Immune Thrombocytopenic Purpura	1
Toxicity of CAR T-Cell Therapy for Multiple Myeloma	1